Paydirt
GM
Insider

Gina Mazzariello

Chief Legal Officer

Gina Mazzariello (Chief Legal Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Amylyx Pharmaceuticals, Inc. (AMLX). The largest single filing was $539K of AMLX (30,000 sh across 2 lots, as filed), executed Jul 9.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$977K
shares × price, as filed
Last traded
Sep 10
Filed Sep 14

Median ADV $78.0M across their filed names

Open performance
Volume by month
$539K$269K$0Oct 2024Apr 2025Oct 2025Apr 2026Aug 2025 · sells $246KOct 2025 · sells $129KJul 2026 · sells $539KSep 2026 · sells $309K
Buys $0 Sells $1.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names
AMLX Amylyx Pharmaceuticals, Inc. AMLX · 0 buys · 4 sells 4 filings
Recent filings
AMLXSALE Amylyx Pharmaceuticals, Inc. View filing → $309K
9,525 sh × $32.46
Exec Sep 10
Filed Sep 14 · 4:00 PM ET
AMLXSALE Amylyx Pharmaceuticals, Inc. View filing → $539K
30,000 sh across 2 lots
Exec Jul 9
Filed Jul 13 · 4:00 PM ET
AMLXSALE Amylyx Pharmaceuticals, Inc. View filing → $129K
8,828 sh × $14.58
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET
AMLXSALE Amylyx Pharmaceuticals, Inc. View filing → $246K
30,000 sh across 2 lots
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET